newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Issues Letter to Stockholders

Delisting Notice Underlines Urgency to Approve Proposal to Authorize a Reverse Stock-Split ENGLEWOOD, Colo., Oct. 4, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), today released the following letter to stockholders from its Chairman, Ke